Doctors might also call them neuroendocrine neoplasms (NENs). But the terms mean the same thing. There are 2 key groups of neuroendocrine cancer: neuroendocrine tumours (NETs) neuroendocrine ...

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.

This recommendation is not intended to affect treatment with elacestrant that was started in the NHS before this guidance was published. People having treatment outside this recommendation may ...

There is a simple discount patient access scheme for elacestrant. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

The management of bone metastases in endocrine-related cancers is a continually evolving field, marked by significant challenges and advances that affect ...

The effects of the endocrine system are slow to initiate and can have long-term effects. Hypoparathyroidism is a rare condition characterized by inadequate levels of parathyroid hormone (PTH ...

Optical measurements through the skin are challenging because they usually represent averages across the various layers of skin that are illuminated. A study in Nature Metabolism uses a depth ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...